A.R.T. Advisors, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 185 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$401,000
-26.4%
10,526
-16.0%
0.02%
-35.5%
Q2 2019$545,000
+37.3%
12,526
+20.1%
0.03%
+29.2%
Q1 2019$397,000
+5.0%
10,426
+25.6%
0.02%
+41.2%
Q4 2017$378,000
-82.8%
8,300
-82.8%
0.02%
-83.2%
Q1 2017$2,197,000
+19.1%
48,200
-15.6%
0.10%
-8.2%
Q4 2016$1,844,000
+235.3%
57,100
+254.7%
0.11%
-38.2%
Q3 2016$550,000
-79.6%
16,100
-79.9%
0.18%
+31.9%
Q2 2016$2,701,000
+5.3%
80,105
+139.8%
0.14%
+10.7%
Q4 2015$2,565,000
+41.5%
33,407
-24.3%
0.12%
+82.1%
Q3 2015$1,813,000
+172.6%
44,134
+368.9%
0.07%
+204.5%
Q2 2015$665,000
-79.0%
9,412
-73.6%
0.02%
-79.8%
Q1 2015$3,165,000
-40.2%
35,631
-40.3%
0.11%
-44.9%
Q4 2014$5,292,000
+60.8%
59,699
+75.7%
0.20%
+30.3%
Q3 2014$3,292,000
+212.6%
33,970
+196.3%
0.15%
+176.4%
Q2 2014$1,053,000
-56.6%
11,465
-67.0%
0.06%
-57.4%
Q1 2014$2,428,000
+249.9%
34,703
+187.4%
0.13%
+248.6%
Q4 2013$694,000
-65.2%
12,075
-70.9%
0.04%
-66.1%
Q3 2013$1,995,000
+35.6%
41,494
-18.2%
0.11%
+127.1%
Q2 2013$1,471,00050,7290.05%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders